Reforming Federal Marijuana Regulations: Democrats Push for Change

Regulations by 2FIRSTS.ai
Jan.31.2024
Reforming Federal Marijuana Regulations: Democrats Push for Change
Democratic senators in the US are pushing for the reform of federal marijuana regulations, aiming to ease restrictions.

According to an article by eltiempolatino on January 31, Democratic senators in the United States Senate are working on reforming President Joe Biden's federal marijuana regulations to ease related restrictions. Democratic senators have written a letter to the Drug Enforcement Administration (DEA) earlier this week, urging a reassessment of the federal classification of marijuana, which originates from a proposal by the Department of Health and Human Services in August.

 

In a proposal, the Department of Health and Human Services has recommended that the Drug Enforcement Administration reclassify marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), sparking a review process. Now, a group of Democratic Senators led by Elizabeth Warren and John Fettman have put forward a bill to completely remove marijuana from the Controlled Substances Act, with the support of majority leader Chuck Schumer.

 

Once marijuana is no longer regulated, it will have far-reaching implications on the cannabis industry and consumers, especially those who rely on marijuana for medical purposes. Despite being classified as a Schedule I drug, alongside heroin and LSD, since 1971, 40 states and Washington D.C. have already legalized its use.

 

The Drug Enforcement Administration (DEA) has confirmed its authority to reclassify drugs based on scientific and medical evaluations, and the White House is expected to release a reclassification notice on the one-year anniversary of the Department of Health and Human Services' recommendation. However, Democratic lawmakers are urging the government to swiftly remove marijuana from Schedule I, which would result in its complete lack of classification. This proposal has garnered support from Democratic Senators Cory Booker of New Jersey and Ron Wyden of Oregon, who have previously co-sponsored comprehensive marijuana reform legislation.

 

Currently, the bill to legalize marijuana is still seeking consensus between the two parties. In 2022, a nationwide proposal to legalize marijuana was passed in the House of Representatives, while the bill called the "SAFE Banking Act" aims to provide banking services for legal cannabis businesses in states and is awaiting a vote in the Senate.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
The U.S. Food and Drug Administration released a programmatic environmental assessment covering nicotine pouches and other oral nicotine products, concluding that their overall environmental impact is generally minimal.
Regulations
May.22
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium’s federal government on Thursday approved a ban on flavored vapes, allowing only tobacco-flavored and unflavored e-cigarettes on the market from September 2028. Health Minister Frank Vandenbroucke said the measure is aimed at protecting the health of children and young people and preventing a new generation from becoming dependent on tobacco.
May.06 by 2FIRSTS.ai
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai